You are here

Story Archive

Primary tabs

Category Titlesort ascending Date Excerpt Attached Images
Headlines TRIUMF and CNL to form strategic partnership to enable ground-breaking cancer treatment 27 September 2018 Leading Canadian laboratories collaborate to produce Actinium-225, a rare medical isotope with the potential to revolutionize the fight against untreatable forms of cancer
TRIUMF and CNL to form strategic partnership to enable ground-breaking cancer treatment
Current Events TRIUMF and CNL announce MOU to collaborate on nuclear science and technology 24 January 2023 The new agreement identifies areas of cooperation that includes the delivery of joint research projects and the sharing of scientific information and equipment.
Current Events TRIUMF and CNL announce first joint production run of actinium-225 23 October 2019 Partnered organizations complete first trial production run of actinium-225, demonstrating capability to produce “the rarest drug on Earth.”
Headlines TRIUMF and BWXT Medical execute agreement for manufacture of Ac-225 based products 13 June 2022 TRIUMF and BWX Technologies, Inc. announced today the execution of a licensing and services agreement that strengthens their existing partnership for the production of medical isotopes.
Current Events TRIUMF and Altera partner on advanced training 06 June 2016 This spring, TRIUMF partnered with Altera Corp., an Intel subsidiary, to offer three industry-leading training workshops designed to keep data acquisition experts at the forefront in their field.
TRIUMF Alumni and Retirees Association
TRIUMF Alumni & Retirees Association (TARA)
Current Events TRIUMF Aids in Increasing Tc-99m Supply 22 July 2011 TRIUMF's Tom Ruth and Tom Morley are hoping to help increase the production of Tc-99m through accelerator-based technologies.
TRIUMF Affiliate Scientists and Engineers

Pages

Subscribe to Recent Stories